Wockhardt Ltd. | WOCKPHARMA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 4,487 | 2,685 | 2,918 | 4,060 | 1,240 |
Short-term investment |
| 0 | 0 | 0 | 0 | 0 |
Accounts receivables |
| 12,607 | 12,427 | 9,177 | 9,180 | 7,970 |
Inventories |
| 8,194 | 6,898 | 7,989 | 7,690 | 6,580 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 2,727 | 2,289 | 4,161 | 4,960 | 6,290 |
Total current assets |
| 28,014 | 24,298 | 24,244 | 25,890 | 22,080 |
Gross property plant... |
| 21,245 | 18,567 | 17,190 | 19,080 | 15,580 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 21,245 | 18,567 | 17,190 | 19,080 | 15,580 |
Work in Progress |
| 8,997 | 8,365 | 6,028 | 3,890 | 4,140 |
Miscellaneous Investment |
| 390 | 5 | 453 | 620 | 640 |
Deferred income taxes |
| 3,864 | 5,484 | 5,141 | 6,850 | 7,230 |
Intangible assets |
| 6,586 | 8,963 | 9,038 | 10,530 | 12,000 |
Goodwill |
| 8,206 | 8,752 | 9,040 | 8,910 | 9,450 |
Other long-term assets |
| 1,009 | 7,356 | 6,594 | 6,660 | 5,710 |
Total non-current assets |
| 50,297 | 57,491 | 53,483 | 56,540 | 54,750 |
Total assets |
| 78,311 | 81,789 | 77,727 | 82,430 | 76,830 |
Short-term debt |
| 5,617 | 9,039 | 10,661 | 15,070 | 16,630 |
Accounts Payable... |
| 8,402 | 8,953 | 5,780 | 9,210 | 8,670 |
Provisions |
| 419 | 1,173 | 598 | 370 | 440 |
Taxes Payable |
| 62 | 10 | 689 | 180 | 220 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 625 | 627 | 690 | 710 |
Other current liabilities |
| 14,004 | 15,173 | 12,828 | 6,550 | 7,680 |
Total current liabilities |
| 28,505 | 34,972 | 31,182 | 32,070 | 34,350 |
Long-term debt |
| 18,915 | 12,409 | 5,029 | 3,550 | 2,240 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 311 | 313 | 285 | 280 | 320 |
Provisions |
| 535 | 456 | 844 | 320 | 260 |
Capital Leases |
| 0 | 3,065 | 2,786 | 2,670 | 2,260 |
Other longterm liabilities |
| 0 | 0 | 0 | 1,520 | 780 |
Total non-current liabilities |
| 19,760 | 16,243 | 8,942 | 8,340 | 5,860 |
Total liabilities |
| 48,265 | 51,215 | 40,124 | 40,410 | 40,210 |
Share Capital |
| 553 | 554 | 554 | 720 | 720 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 26,195 | 26,163 | 33,214 | 37,770 | 32,820 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 3,298 | 3,858 | 3,835 | 3,530 | 3,080 |
Total Equity |
| 30,046 | 30,575 | 37,603 | 42,020 | 36,620 |
Total Liabilities and Equity |
| 78,311 | 81,789 | 77,727 | 82,430 | 76,830 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |